Life Sciences

Continued growth predicted for NGS

The demand in Next Generation Sequencing (NGS) technology shows no signs of slowing down as market research firm BCC Research predicts that the clinical NGS market will increase to more than $10.5 Billion by 2022

Illumina and IDT Partnership to expedite exome enrichment

Illumina has announced an expanded partnership with Integrated DNA Technologies (IDT) to develop solutions for next-generation sequencing (NGS) library preparation multiplexing and a co-marketing agreement that links Illumina library prep with the IDT Exome Enrichment

Subscribe to RSS - Life Sciences